Teresa Moran Bueno

h-index

Research activity per year

Research interests

Educational management

General quality indicators of scientific research

Education/Academic qualification

Unknown, Masters, Master Universitario de Competencias Médicas avanzadas: Modelos organizativos de atención en oncología y atención al enfermo avanzado", Universitat de Barcelona (UB), Institut Català d'Oncologia (ICO)

Award Date: 20 Apr 2021

Unknown, Masters, Master en Oncologia Molecular: Bases Moleculares del Cáncer. Nota final Excelente, CNIO, Spanish National Cancer Research Centre, Programa Patol Mol

2019 → 2020

External positions

Presidenta Comisión Clínica Oncoruta Cáncer de Pulmón, Institut Català d'Oncologia a Badalona

Jan 2023 → …

Coordinadora de Unidad de Tumores Torácicos, Institut Català d'Oncologia a Badalona

Jan 2022 → Dec 2023

Coordinadora de Comité de Tumores del Tórax, Institut Català d'Oncologia a Badalona

2022 → …

Coordinadora Unidad Funcional de Cáncer de Pulmón, Institut Català d'Oncologia a Badalona

Dec 2019 → …

Vocal del Biobanco , Germans Trias i Pujol Health Sciences Research Institute (IGTP)

2013 → …

Referente local de Tumores Torácicos, Institut Català d'Oncologia a Badalona

2012 → …

Clinical Research Fellow, Massachusetts General Hospital - Harvard Medical School

Jun 2011 → Jun 2012

Miembro de ESMO, European Society of Medical Oncology (ESMO)

2011 → …

Miembro de SEOM, Sociedad Española de Oncología Médica (SEOM)

2010 → …

Tutora de residentes de Oncología Médica , Institut Català d'Oncologia a Badalona

2005 → …

Miembro de Grupo Español de Cáncer de Pulmon, Spanish lung cancer group (Grupo Español de Cancer de Pulmón (GECP))

2004 → …

Médico Adjunto Servicio de Oncología Médica, Institut Català d'Oncologia a Badalona

Jul 2003 → …

Miembro del Comité de Tumores del Tórax , Institut Català d'Oncologia a Badalona

2002 → …

Formación Especializada (MIR) Oncología Médica, Germans Trias i Pujol University Hospital

1999 → 2003

Licenciada en Medicina y Cirugia, University of Navarra (UNA)

Oct 1991 → Jun 1997

Fingerprint

Dive into the research topics where Teresa Moran Bueno is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

1 Similar Profiles

103 Article
18 Review article
4 Chapter

Efficacy and safety of mRNA1273 SARS-CoV-2 vaccination in hematopoietic stem cell transplant recipients: Single center experience
Annex. Members of the study group, 12 Apr 2024, In: Medicina clinica. 162, 7, p. 313-320 8 p.
Research output: Contribution to journal › Article › Research › peer-review
HMGB1 Expression Levels Correlate with Response to Immunotherapy in Non-Small Cell Lung Cancer
González-Cao, M., Cai, X., Bracht, J. W. P., Han, X., Yang, Y., Pedraz-Valdunciel, C., Morán, T., García-Corbacho, J., Aguilar, A., Bernabé, R., De Marchi, P., da Silva, L. S., Leal, L. F., Reis, R. M., Codony-Servat, J., Jantus-Lewintre, E., Molina-Vila, M. A., Cao, P. & Rosell, R., 1 May 2024, In: Lung Cancer: Targets and Therapy. 15, p. 55-67 13 p.
Research output: Contribution to journal › Article › Research › peer-review

Open Access
5 Link opens in a new tab Citations (Scopus)
Author Correction: BIM and mTOR expression levels predict outcome to erlotinib in EGFR-mutant non-small-cell lung cancer (Scientific Reports, (2015), 5, 1, (17499), 10.1038/srep17499)
Karachaliou, N., Codony-Servat, J., Teixidó, C., Pilotto, S., Drozdowskyj, A., Codony-Servat, C., Giménez-Capitán, A., Molina-Vila, M. A., Bertrán-Alamillo, J., Gervais, R., Massuti, B., Morán, T., Majem, M., Felip, E., Carcereny, E., García-Campelo, R., Viteri, S., González-Cao, M., Morales-Espinosa, D. & Verlicchi, A. & 14 others, Crisetti, E., Chaib, I., Santarpia, M., Luis Ramírez, J., Bosch-Barrera, J., Felipe Cardona, A., de Marinis, F., López-Vivanco, G., Miguel Sánchez, J., Vergnenegre, A., Sánchez Hernández, J. J., Sperduti, I., Bria, E. & Rosell, R., Dec 2023, In: SCIENTIFIC REPORTS. 13, 1, 2 p., 3620.
Research output: Contribution to journal › Article › Research › peer-review

Open Access
1 Link opens in a new tab Citation (Scopus)
Characterization of a cohort of metastatic lung cancer patients harboring KRAS mutations treated with immunotherapy: differences according to KRAS G12C vs. non-G12C
Notario, L., Cucurull, M., Cerdà, G., Sanz, C., Carcereny, E., Muñoz-Mármol, A., Hernández, A., Domènech, M., Morán, T., Sánchez-Céspedes, M., Costa, M., Mate, J. L., Esteve, A. & Saigí, M., 2023, In: Frontiers in Oncology. 13, 1239000.
Research output: Contribution to journal › Article › Research › peer-review

Open Access
8 Link opens in a new tab Citations (Scopus)
Correction to: SEOM-GECP Clinical guidelines for diagnosis, treatment and follow-up of small-cell lung cancer (SCLC) (2022) (Clinical and Translational Oncology, (2023), 25, 9, (2679-2691), 10.1007/s12094-023-03216-3)
García-Campelo, R., Sullivan, I., Arriola, E., Insa, A., Juan Vidal, O., Cruz-Castellanos, P., Morán, T., Reguart, N., Zugazagoitia, J. & Dómine, M., Sept 2023, In: Clinical and Translational Oncology. 25, 9, p. 2760-2762 3 p.
Research output: Contribution to journal › Article › Research › peer-review

Open Access
2 Link opens in a new tab Citations (Scopus)

Mutaciones del gen del receptor del factor de crecimiento epidémico (EGFR) en pacientes con carcinoma no microcítico de pulmón: cribado poblacional, significado predictivo y pronóstico y estrategias terapéuticas a la progresión.
Moran Bueno, M. T. (Author), Felip Font, E. (Director), Giralt Lopez De Sagredo, J. (Tutor) & Rosell Costa, R. (Director), 15 Jul 2019
Student thesis: Doctoral thesis

Teresa Moran Bueno

Personal profile

Research interests

Educational management

General quality indicators of scientific research

Education/Academic qualification

External positions

Fingerprint

Collaborations and top research areas from the last five years

Dive into details

Efficacy and safety of mRNA1273 SARS-CoV-2 vaccination in hematopoietic stem cell transplant recipients: Single center experience

HMGB1 Expression Levels Correlate with Response to Immunotherapy in Non-Small Cell Lung Cancer

Author Correction: BIM and mTOR expression levels predict outcome to erlotinib in EGFR-mutant non-small-cell lung cancer (Scientific Reports, (2015), 5, 1, (17499), 10.1038/srep17499)

Characterization of a cohort of metastatic lung cancer patients harboring KRAS mutations treated with immunotherapy: differences according to KRAS G12C vs. non-G12C

Correction to: SEOM-GECP Clinical guidelines for diagnosis, treatment and follow-up of small-cell lung cancer (SCLC) (2022) (Clinical and Translational Oncology, (2023), 25, 9, (2679-2691), 10.1007/s12094-023-03216-3)

Mutaciones del gen del receptor del factor de crecimiento epidémico (EGFR) en pacientes con carcinoma no microcítico de pulmón: cribado poblacional, significado predictivo y pronóstico y estrategias terapéuticas a la progresión.

Teresa Moran Bueno

Personal profile

Research interests

Educational management

General quality indicators of scientific research

Education/Academic qualification

External positions

Fingerprint

Collaborations and top research areas from the last five years

Research output

Efficacy and safety of mRNA1273 SARS-CoV-2 vaccination in hematopoietic stem cell transplant recipients: Single center experience

HMGB1 Expression Levels Correlate with Response to Immunotherapy in Non-Small Cell Lung Cancer

Author Correction: BIM and mTOR expression levels predict outcome to erlotinib in EGFR-mutant non-small-cell lung cancer (Scientific Reports, (2015), 5, 1, (17499), 10.1038/srep17499)

Characterization of a cohort of metastatic lung cancer patients harboring KRAS mutations treated with immunotherapy: differences according to KRAS G12C vs. non-G12C

Correction to: SEOM-GECP Clinical guidelines for diagnosis, treatment and follow-up of small-cell lung cancer (SCLC) (2022) (Clinical and Translational Oncology, (2023), 25, 9, (2679-2691), 10.1007/s12094-023-03216-3)

Thesis

Mutaciones del gen del receptor del factor de crecimiento epidémico (EGFR) en pacientes con carcinoma no microcítico de pulmón: cribado poblacional, significado predictivo y pronóstico y estrategias terapéuticas a la progresión.